Buccal drug delivery systems represent an innovative strategy for the administration of therapeutic agents via the oral mucosa. This approach bypasses the hepatic first‐pass metabolism, thereby ...

What is Targeted Drug Delivery? Targeted drug delivery is a cutting-edge approach in nanomedicine that aims to selectively transport therapeutic agents to specific tissues, cells, or even ...

Biomedical engineers have developed a new hydrogel-based delivery system that balances the acidic environment in a tumor and greatly enhances the cancer-fighting activity of the chemotherapeutic drug ...

Scientists at Xi'an Jiaotong-Liverpool University (XJTLU) and Nanjing University in China have developed a new drug delivery system that could improve how treatments of cancers and other diseases are ...

Optimizing drug delivery to the lymphatic system is essential for effective cancer treatment, as lymph node (LN) metastasis ...

A study published in the journal Science Translational Medicine describes the development and validation of an octopus sucker-inspired buccal mucosa suction patch as a novel drug delivery system. The ...

(RTTNews) - Polyrizon Ltd. (PLRZ), a development-stage biotech company, has filed a divisional patent application with the Israel Patent Office for its Trap & Target or T&T intranasal drug delivery ...

When cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the patient’s body surface area. This is estimated by plugging the patient’s height and weight into an equation ...

A magnetically guided microrobotics system is capable of navigating the body’s intricate passageways and vasculature to deliver drugs with pinpoint accuracy, according to a new study. The novel system ...

DDS can be based on physical mechanisms like osmosis, diffusion, erosion, dissolution, and electro-transport or biochemical methods like monoclonal antibodies, gene therapy, vector systems, ...

CARY, N.C.--(BUSINESS WIRE)--Focal Medical, Inc., a privately held, biopharmaceutical company developing novel precision therapeutic products today announced successful completion of the nonclinical ...